San Diego CA (SPX) Dec 17, 2010
Using an automated screening technique developed by pharmaceutical companies to find new drugs, a team of researchers from UC San Diego and three other research institutions has discovered a molecule with the most potent effects ever seen on the biological clock.
Dubbed by the scientists "longdaysin," for its ability to dramatically slow down the biological clock, the new compound and the application of their screening method to the discovery of other clock-shifting chemicals could pave the way for a host of new drugs to treat severe sleep disorders or quickly reset the biological clocks of jet-lagged travelers who regularly travel across multiple time zones.
"Theoretically, longdaysin or a compound like it could be used to correct sleep disorders such as the genetic disorder familial advanced sleep syndrome, which is characterized by a clock that's running too fast," said Steve Kay, dean of UCSD's Division of Biological Sciences, who headed the research team, which published its findings in the December 14 issue of the journal PLoS Biology.
"A compound that makes the clock slow down or speed up can also be used to phase-shift the clock-in other words, to bump or reset the hands of the clock. This would help your body catch up when it is jet lagged or reset it to a normal day-night cycle when it has been thrown out of phase by shift work."
The researchers demonstrated the dramatic effects of longdaysin by lengthening the biological clocks of larval zebra fish by more than 10 hours.
"Longdaysin is the champion by far in how much it can move the clock," said Kay, whose laboratory at UCSD had found compounds in previous studies that could shift the biological clock by as much as several hours at most. "We were really surprised to find out how much you can slow down the biological clock with this compound and still have a clock that is running."
Biologists in Kay's laboratory and the nearby Genomics Institute of the Novartis Research Foundation, who were led by Tsuyoshi Hirota, the first author of the paper, discovered longdaysin by screening thousands of compounds with a chemical robot that tested the reaction of each compound with a line of human bone cancer cells that the researchers' genetically modified so that they could visually see changes in the cells' circadian rhythms.
This was done by attaching in the cells a clock gene to a luciferase gene used by fireflies to glow at night, so that the cells glowed when the biological clock was activated.
A chemical robot screened more than 120,000 potential compounds from a chemical library into individual micro-titer wells, a system used by drug companies called high-throughput screening, and automatically singled out those molecules found to have the biggest effects on the biological clock.
Once Kay's group had isolated longdaysin, it turned to biological chemists in Peter Schultz's laboratory at The Scripps Research Institute to characterize the molecule and figure out the mechanisms of how it lengthened the biological clock.
That analysis showed that three separate protein kinases on the compound were responsible for the dramatic effect of longdaysin, one of which, CK1alpha, had previously been ignored by chronobiology researchers.
"Because this compound doesn't just hit one target, but multiple targets, it showed us that if you want to shift the biological clock in a major way you have to hit multiple kinases," said Kay.
The researchers then showed that longdaysin had the same effect of lengthening the biological clock in mouse tissue samples and zebra fish larvae that carried luciferase genes attached to their clock genes.
"We were really encouraged to find that when we added longdaysin to these living zebra fish, we lengthened the biological clock and didn't see any obvious deleterious effects," said Kay.
"They grow normally while they are exposed to this compound. That showed us that our high-throughput assay works and accurately predicts how the compound works on the biological clock of a living fish. The next thing to do is to try this in a mammalian system."
Kay's research team plans to test longdaysin on mice in the near future, but its goal isn't to develop longdaysin into a drug.
"Longdaysin is not as potent as we would like," he adds. "This will be a tool for research."
Other co-authors of the paper besides Hirota and Schultz were Warren Lewis, Eric Zhang, Ghislain Breton and David Traver of UCSD; Jae Wook Lee of TSRI; Xianzhong Liu, Michael Garcia Eric Peters of the Genomics Institute of the Novartis Research Foundation; and Pierre Etchegaray of the University of Massachusetts Medical School. The study was funded by grants from the National Institutes of Health.
Share This Article With Planet Earth
UC San Diego
All About Human Beings and How We Got To Be Here
Woman who knows no fear could offer brain clues
Washington (AFP) Dec 16, 2010
US scientists have discovered a woman with a rare brain disease that makes her afraid of nothing - not a huge snake lurking near her children, not a knife to her throat, and certainly not a horror movie. The woman cannot experience fear because of a condition that has destroyed the part of her brain - the amygdala - where researchers say they believe the feeling of fear is made. Over ... read more
Caricom-Australia chide empty promises to Haiti|
Tearful homecoming for Pakistan flood survivors
Clinton attacks slow Haiti quake progress
Clinton Haiti meeting moved due to unrest
Physicist Developing And Improving Designer optical Materials
Japan's Sharp to build LCD lines for smartphones: report
Endeavor Power Launches Endeavor Metals
Apple to open Mac App Store on January 6
A Positive Step In The Face of Uncertainty
Warm water may be hurting cod food supply
EU reduces fishing quotas to save cod
US water has large amounts of likely carcinogen: study
Arctic Sea Ice Greenhouse Gases And Polar Bear Habitat
Bering Sea Was Ice-Free And Full Of Life During Last Warm Period
Arctic icecap safe from runaway melting: study
Russia plans annual arctic conferences
Australians buy cows and sheep with a mouse
Goji Berries Have A Significant Placebo Effect
German giants Bayer, BASF team up on GM rice
McDonald's to speed up China expansion
Volcano in Guatemala rumbling
Colombia faces rising death toll in floods
EU clears aid for flood-ravaged eastern Europe
New Way Found Of Monitoring Volcanic Ash Cloud
China not opposed to Sudan leader's arrest: WikiLeaks
Frontline Ivory Coast town fears new civil war
Interim leader urges army must back new Guinea president
Gambia denies it was intended recipient of Iran arms
Researchers Discover Compound With Potent Effects On Biological Clock
Our Flawed Understanding of Risk Helps Drive Financial Market Instability
Woman who knows no fear could offer brain clues
Early Settlers Rapidly Transformed New Zealand Forests With Fire
|The content herein, unless otherwise known to be public domain, are Copyright 1995-2010 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement|